These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 31300611)
1. Activation of HIF-1 Schoos A; Gabriel C; Knab VM; Fux DA J Pharmacol Exp Ther; 2019 Sep; 370(3):480-489. PubMed ID: 31300611 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells. Sun YZ; Cai N; Liu NN Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640 [TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
4. 12-Deoxyphorbol 13-palmitate inhibits the expression of VEGF and HIF-1α in MCF-7 cells by blocking the PI3K/Akt/mTOR signaling pathway. Yang Y; Cong H; Han C; Yue L; Dong H; Liu J Oncol Rep; 2015 Oct; 34(4):1755-60. PubMed ID: 26239613 [TBL] [Abstract][Full Text] [Related]
5. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 increases hypoxia-inducible factor-1 and vascular endothelial growth factor to promote angiogenesis in gastric carcinoma. Huang SP; Wu MS; Shun CT; Wang HP; Hsieh CY; Kuo ML; Lin JT J Biomed Sci; 2005; 12(1):229-41. PubMed ID: 15864753 [TBL] [Abstract][Full Text] [Related]
8. Suppression of tumor angiogenesis by metformin treatment via a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis. Wang J; Li G; Wang Y; Tang S; Sun X; Feng X; Li Y; Bao G; Li P; Mao X; Wang M; Liu P Oncotarget; 2015 Dec; 6(42):44579-92. PubMed ID: 26625311 [TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibition prevents hypoxia-induced increase in hypoxia-inducible factor-1alpha (HIF-1alpha) and vascular endothelial growth factor (VEGF) by regulating 26 S proteasome-mediated protein degradation in human colon cancer cells. Tammali R; Saxena A; Srivastava SK; Ramana KV J Biol Chem; 2011 Jul; 286(27):24089-100. PubMed ID: 21576240 [TBL] [Abstract][Full Text] [Related]
11. In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. Shi YH; Wang YX; Bingle L; Gong LH; Heng WJ; Li Y; Fang WG J Pathol; 2005 Mar; 205(4):530-6. PubMed ID: 15714461 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 induces hypoxia-inducible factor-1alpha stabilization and nuclear localization in a human prostate cancer cell line. Liu XH; Kirschenbaum A; Lu M; Yao S; Dosoretz A; Holland JF; Levine AC J Biol Chem; 2002 Dec; 277(51):50081-6. PubMed ID: 12401798 [TBL] [Abstract][Full Text] [Related]
13. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment. De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519 [TBL] [Abstract][Full Text] [Related]
14. Impact of cyclic hypoxia on HIF-1alpha regulation in endothelial cells--new insights for anti-tumor treatments. Martinive P; Defresne F; Quaghebeur E; Daneau G; Crokart N; Grégoire V; Gallez B; Dessy C; Feron O FEBS J; 2009 Jan; 276(2):509-18. PubMed ID: 19077164 [TBL] [Abstract][Full Text] [Related]
15. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition. Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463 [TBL] [Abstract][Full Text] [Related]
16. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Tanaka H; Yamamoto M; Hashimoto N; Miyakoshi M; Tamakawa S; Yoshie M; Tokusashi Y; Yokoyama K; Yaginuma Y; Ogawa K Cancer Res; 2006 Dec; 66(23):11263-70. PubMed ID: 17145871 [TBL] [Abstract][Full Text] [Related]
17. Bisphosphonates suppress insulin-like growth factor 1-induced angiogenesis via the HIF-1alpha/VEGF signaling pathways in human breast cancer cells. Tang X; Zhang Q; Shi S; Yen Y; Li X; Zhang Y; Zhou K; Le AD Int J Cancer; 2010 Jan; 126(1):90-103. PubMed ID: 19569175 [TBL] [Abstract][Full Text] [Related]
18. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells. Chen MC; Lee CF; Huang WH; Chou TC Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116 [TBL] [Abstract][Full Text] [Related]
19. DADLE enhances viability and anti-inflammatory effect of human MSCs subjected to 'serum free' apoptotic condition in part via the DOR/PI3K/AKT pathway. Reddy LVK; Sen D Life Sci; 2017 Dec; 191():195-204. PubMed ID: 29054455 [TBL] [Abstract][Full Text] [Related]
20. Antitumor effect of a selective COX-2 inhibitor, celecoxib, may be attributed to angiogenesis inhibition through modulating the PTEN/PI3K/Akt/HIF-1 pathway in an H₂₂ murine hepatocarcinoma model. Sui W; Zhang Y; Wang Z; Wang Z; Jia Q; Wu L; Zhang W Oncol Rep; 2014 May; 31(5):2252-60. PubMed ID: 24647425 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]